The national version of the drug for the record system is about to attack, pharmaceutical representatives how to do?

Pharmaceutical Network Industry Dynamics: In the 1980s, with the entry of foreign pharmaceutical companies into China, the profession of pharmaceutical representative became known.
, they were active in medical institutions and doctors, mainly in the future to introduce new drug knowledge and collect clinical needs.
but with the increasingly fierce competition in the pharmaceutical market, pharmaceutical representatives of a variety of "gold" marketing means began to be criticized in the industry.
in order to make the pharmaceutical representative of this profession return to its meaning, in recent years, the state began to vigorously promote the pharmaceutical representative filing system and a series of measures to implement, the pharmaceutical representative's illegal sales practices to be strictly control.
In recent times, the State Drug Administration and the Health and Safety Commission have issued the "Pharmaceutical Representative Filing Management Measures (Trial) (Draft for Comments)", as well as the "Notice on the issuance of the 2020 medical industry style construction work special action plan", the key position "Pharmaceutical Representative" once again put in the spotlight, so that a large number of pharmaceutical representatives in an awkward position.
Among them, it is worth noting that, in contrast to the 2017 Measures for the Administration of the Registration and Filing of Pharmaceutical Representatives (Trial) (Draft for Comments), the new methods have clearer and stricter provisions on the subject responsibilities of pharmaceutical representatives for filing and the way to deal with prohibited matters, and pharmaceutical enterprises must assume the training, education and management responsibilities of pharmaceutical representatives, in the face of new situations and new requirements.
However, due to the quality of pharmaceutical representatives of domestic pharmaceutical companies and the level of internal control level is not the same, the industry believes that after the implementation of the pharmaceutical representative filing system, face-to-face visits and marketing compliance will become an unchangeable trend, it is estimated that some enterprises will face greater sales challenges.
In this context, pharmaceutical companies must raise awareness, from the ideological attention, really in accordance with the requirements of specialization to train and manage pharmaceutical representatives, resolutely take the path of academic marketing, put an end to "with gold" sales, so that pharmaceutical representatives of this profession bright, so that hospital marketing normalization.
first of all, pharmaceutical representatives should recognize from the ideological medicine marketing compliance is an inevitable trend, resolutely abandon the "gold" sales and relationship marketing.
, according to the regulations, re-grooming the sales system and daily assessment management, improve the provisions, strictly put an end to the pharmaceutical representative "with gold" sales.
addition, pharmaceutical companies need to speed up the restructuring of their products so that pharmaceutical representatives can conduct academic promotion and general sales of products in key hospitals.
addition, there are industry analysts believe that the future development opportunities of pharmaceutical representatives should also be looking for new sales channels and reach the target population.
the 2030 health planning, graded diagnosis and treatment, volume procurement and other policies, the future broad grass-roots market will become an important position for pharmaceutical companies to sink.
is due to the broad grass-roots market and difficult to universal coverage, pharmaceutical companies on the expansion of the demand for pharmaceutical representatives caused.
In the big environment, medical representatives should think more about how to become always "chosen" or "not eliminated" people, suggested that the new representatives should have "rapid learning and development" of the core competitiveness, the old representatives should have "exclusive resources" of the core competitiveness.
, the essence of medical representative is academic promotion, technical consultation, the essence of the rules is the right way.
.